73
Views
15
CrossRef citations to date
0
Altmetric
Original Research

LINE-1 ORF-1p enhances the transcription factor activity of pregnenolone X receptor and promotes sorafenib resistance in hepatocellular carcinoma cells

, , , , , , , , , , , & show all
Pages 4421-4438 | Published online: 10 Oct 2018

References

  • DouvilleCSpringerSKindeIDetection of aneuploidy in patients with cancer through amplification of long interspersed nucleotide elements (LINEs)Proc Natl Acad Sci U S A201811581871187629432176
  • LiuNLeeCHSwigutTSelective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulatorsNature2018553768722823229211708
  • HanYXuJKimJWuXGuJLINE-1 methylation in peripheral blood leukocytes and clinical characteristics and prognosis of prostate cancer patientsOncotarget2017855940209402729212206
  • OhkaFNatsumeAMotomuraKThe global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for gliomaPLoS One201168e2333221829728
  • XiaZCochraneDRAnglesioMSLINE-1 retrotransposon-mediated DNA transductions in endometriosis associated ovarian cancersGynecol Oncol201714764264729032825
  • SokolowskiMChyncesMdeHaroDChristianCMBelancioVPTruncated ORF1 proteins can suppress LINE-1 retrotransposition in transNucleic Acids Res20174595294530828431148
  • FengFLuYYZhangFLong interspersed nuclear element ORF-1 protein promotes proliferation and resistance to chemotherapy in hepatocellular carcinomaWorld J Gastroenterol20131971068107823466962
  • ZhuYJZhengBWangHYChenLNew knowledge of the mechanisms of sorafenib resistance in liver cancerActa Pharmacol Sin201738561462228344323
  • FengFJiangQCaoSPregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinomaBiochim Biophys Acta20181862410171030
  • MaDJiaHQinMMiR-122 Induces radiosensitization in non-small cell lung cancer cell lineInt J Mol Sci2015169221372215026389880
  • JiQXuXLiLmiR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14Cell Death Dis2017810e310329022909
  • LuYFengFYangYLINE-1 ORF-1p functions as a novel androgen receptor co-activator and promotes the growth of human prostatic carcinoma cellsCell Signal201325247948923153584
  • YangQFengFZhangFLINE-1 ORF-1p functions as a novel HGF/ETS-1 signaling pathway co-activator and promotes the growth of MDA-MB-231 cellCell Signal201325122652266024012497
  • ChenYFengFGaoXMiRNA153 reduces effects of chemotherapeutic agents or small molecular kinase inhibitor in HCC cellsCurr Cancer Drug Targets201515317618725714700
  • YangYPQuJHChangXJHigh intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinomaJ Transl Med2013114123414367
  • YuanBChengLChiangHCA phosphotyrosine switch determines the antitumor activity of ERβJ Clin Invest201412483378339024960160
  • CaoPFengFDongGEstrogen receptor α enhances the transcriptional activity of ETS-1 and promotes the proliferation, migration and invasion of neuroblastoma cell in a ligand dependent mannerBMC Cancer20151549126122040
  • LinJDingLJinRFour and a half LIM domains 1 (FHL1) and receptor interacting protein of 140kDa (RIP140) interact and cooperate in estrogen signalingInt J Biochem Cell Biol20094171613161819401155
  • MaHYaoYWangCTranscription factor activity of estrogen receptor α activation upon nonylphenol or bisphenol A treatment enhances the in vitro proliferation, invasion, and migration of neuro-blastoma cellsOnco Targets Ther201693451346327366082
  • DongZQiRGuoXMiR-223 modulates hepatocellular carcinoma cell proliferation through promoting apoptosis via the Rab1-mediated mTOR activationBiochem Biophys Res Commun2017483163063727998765
  • ZhuMLiMZhangFFBI-1 enhances ETS-1 signaling activity and promotes proliferation of human colorectal carcinoma cellsPLoS One201495e9804124857950
  • RenHRenBZhangJAndrogen enhances the activity of ETS-1 and promotes the proliferation of HCC cellsOncotarget201786510927110928829312607
  • ZhangYZengDCaoJInteraction of quindoline derivative with telomeric repeat-containing RNA induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2Biochim Biophys Acta201718611232463256
  • LiuZCNingFWangHFEpidermal growth factor and tumor necrosis factor α cooperatively promote the motility of hepatocellular carcinoma cell lines via synergistic induction of fibronectin by NF-κB/p65Biochim Biophys Acta1861201725682582
  • WuMZhaoGZhuangXTriclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cellsOnco Targets Ther2018112945295429849464
  • XiongSKlausenCChengJCLeungPCKTGFβ1 induces endometrial cancer cell adhesion and migration by up-regulating integrin αvβ3 via SMAD-independent MEK-ERK1/2 signalingCell Signal2017349210128336232
  • WuXLiZShenYThe small molecule CS1 inhibits mitosis and sister chromatid resolution in HeLa cellsBiochim Biophys Acta20181862511341147
  • ZhengBGengLZengLLiuFHuangQAKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axisCell Signal20184512213129374601
  • JiaHYangQWangTRhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agentsBiochim Biophys Acta2016186071417143027091611
  • AnLLiDDChuHXTerfenadine combined with epirubicin impedes the chemo-resistant human non-small cell lung cancer both in vitro and in vivo through EMT and Notch reversalPharmacol Res201712410511528754458
  • XuXFanZLiangCA signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivityNat Commun201781405928094252
  • ZhangYLiDJiangQNovel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of sorafenib on hepatocellular carcinoma cellsCell Death Dis20189774329970890
  • XieHTianSYuHA new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinomaOnco Targets Ther2018113257326529910621
  • KimDWTalatiCKimRHepatocellular carcinoma (HCC): beyond sorafenib-chemotherapyJ Gastrointest Oncol20178225626528480065
  • HouJHongZFengFA novel chemotherapeutic sensitivity-testing system based on collagen gel droplet embedded 3D-culture methods for hepatocellular carcinomaBMC Cancer201717172929117859
  • FengFJiangQJiaHWhich is the best combination of TACE and sorafenib for advanced hepatocellular carcinoma treatment? A systematic review and network meta-analysisPharmacol Res20181358910129959032
  • YangYYeYCChenYCrosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviorsCell Death Dis20189879330022048
  • ShaoZLiYDaiWETS-1 induces sorafenib-resistance in hepatocellular carcinoma cells via regulating transcription factor activity of PXRPharmacol Res201813518820030114438
  • RajyaguruDJBorgertAJSmithALRadiofrequency ablation versus stereotactic body radiotherapy for localized hepatocellular carcinoma in nonsurgically managed patients: analysis of the National Cancer DatabaseJ Clin Oncol201836660060829328861
  • LiFLiNSangJHighly elevated soluble Tim-3 levels correlate with increased hepatocellular carcinoma risk and poor survival of hepatocellular carcinoma patients in chronic hepatitis B virus infectionCancer Manag Res20181094195129760564
  • ZhaoJBaiZFengFCross-talk between EPAS-1/HIF-2α and PXR signaling pathway regulates multi-drug resistance of stomach cancer cellInt J Biochem Cell Biol201672738826783937
  • KuczynskiEALeeCRManSChenEKerbelRSEffects of sorafenib dose on acquired reversible resistance and toxicity in hepatocellular carcinomaCancer Res201575122510251925908587
  • EdgintonANZimmermanEIVasilyevaABakerSDPanettaJCSorafenib metabolism, transport, and enterohepatic recycling: physiologically based modeling and simulation in miceCancer Chemother Pharmacol20167751039105227053087
  • IngersollMAChouYWLinJSp66Shc regulates migration of castration-resistant prostate cancer cellsCell Signal20184611429462661
  • MarquetPAlbanoLWoillardJBComparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipientsPharmacol Res2018129849429229354
  • WangJGanCSparidansRWP-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) affect brain accumulation and intestinal disposition of encorafenib in micePharmacol Res201812941442329155017
  • AmselemJVigourouxMOberhaensliSEvolution of the EKA family of powdery mildew avirulence-effector genes from the ORF 1 of a LINE retrotransposonBMC Genomics20151691726556056
  • CookPRJonesCEFuranoAVPhosphorylation of ORF1p is required for L1 retrotranspositionProc Natl Acad Sci U S A2015112144298430325831499
  • HornAVKlawitterSHeldUHuman LINE-1 restriction by APOBEC3C is deaminase independent and mediated by an ORF1p interaction that affects LINE reverse transcriptase activityNucleic Acids Res201442139641624101588
  • ZhuYFengFYuJL1-ORF1p, a Smad4 interaction protein, promotes proliferation of HepG2 cells and tumorigenesis in miceDNA Cell Biol201332953154023863096